Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
b-cell chronic lymphocytic leukemia | — | D015451 | C91.1 |
Expiration | Code | ||
---|---|---|---|
alemtuzumab, Campath , Genzyme Corporation | |||
2108-05-07 | Orphan excl. | ||
alemtuzumab, Lemtrada, Genzyme Corporation | |||
2108-05-07 | Orphan excl. |
Code | Description |
---|---|
J0202 | Injection, alemtuzumab, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 4 | 3 | 3 | 3 | 19 | 30 |
Kidney transplantation | D016030 | — | — | 4 | 7 | 2 | 5 | 4 | 19 |
Relapsing-remitting multiple sclerosis | D020529 | EFO_0003929 | — | — | 2 | 5 | 4 | 3 | 14 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | 2 | 3 | — | 2 | 1 | 6 |
Kidney diseases | D007674 | EFO_0003086 | N08 | 2 | 3 | — | 1 | 1 | 5 |
Renal insufficiency | D051437 | HP_0000083 | N19 | 2 | 2 | — | 2 | — | 4 |
Graft rejection | D006084 | — | — | — | 1 | — | 2 | 1 | 4 |
Vasculitis | D014657 | HP_0002633 | — | 1 | — | — | 1 | — | 2 |
Chronic inflammatory demyelinating polyradiculoneuropathy | D020277 | EFO_1000868 | G61.81 | — | — | — | 1 | — | 1 |
Granulomatosis with polyangiitis | D014890 | EFO_0005297 | M31.3 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | 11 | 42 | 2 | — | 3 | 48 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 8 | 32 | 2 | — | 6 | 44 |
Sickle cell anemia | D000755 | EFO_0000697 | D57 | 15 | 26 | 2 | — | 3 | 35 |
Myelodysplastic syndromes | D009190 | — | D46 | 7 | 22 | 2 | — | — | 24 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 6 | 15 | 1 | — | 1 | 17 |
Aplastic anemia | D000741 | HP_0001915 | D61.9 | 3 | 12 | 1 | — | 4 | 17 |
Myeloid leukemia acute | D015470 | — | C92.0 | 5 | 10 | 2 | — | — | 13 |
Graft vs host disease | D006086 | — | D89.81 | 3 | 7 | 1 | — | 1 | 11 |
T-cell lymphoma peripheral | D016411 | — | — | 2 | 8 | 1 | — | — | 10 |
Thalassemia | D013789 | EFO_1001996 | D56 | 2 | 7 | 1 | — | 1 | 10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 10 | 26 | — | — | 3 | 33 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 8 | 11 | — | — | 3 | 18 |
Hodgkin disease | D006689 | — | C81 | 3 | 12 | — | — | 1 | 13 |
Multiple myeloma | D009101 | — | C90.0 | 4 | 10 | — | — | 1 | 11 |
Myeloproliferative disorders | D009196 | — | D47.1 | 4 | 7 | — | — | 1 | 10 |
Lymphoproliferative disorders | D008232 | Orphanet_2442 | D47.9 | 2 | 8 | — | — | 1 | 9 |
Hematologic neoplasms | D019337 | — | — | 4 | 6 | — | — | 1 | 8 |
Primary immunodeficiency diseases | D000081207 | — | — | 2 | 7 | — | — | 1 | 8 |
Hemoglobinopathies | D006453 | — | D58.2 | 4 | 7 | — | — | — | 8 |
Hemophagocytic lymphohistiocytosis | D051359 | — | D76.1 | 2 | 6 | — | — | 1 | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lysosomal storage diseases | D016464 | — | — | 1 | — | — | — | 1 | 2 |
Systemic lupus erythematosus | D008180 | HP_0002725 | M32 | 2 | — | — | — | — | 2 |
Melanoma | D008545 | — | — | 1 | — | — | — | — | 1 |
Germ cell and embryonal neoplasms | D009373 | — | — | 1 | — | — | — | — | 1 |
Gastrointestinal stromal tumors | D046152 | EFO_0000505 | C49.A | 1 | — | — | — | — | 1 |
Rhabdoid tumor | D018335 | — | — | 1 | — | — | — | — | 1 |
Ewing sarcoma | D012512 | EFO_0000173 | — | 1 | — | — | — | — | 1 |
Rhabdomyosarcoma | D012208 | — | — | 1 | — | — | — | — | 1 |
Large cell carcinoma | D018287 | — | — | 1 | — | — | — | — | 1 |
Wilms tumor | D009396 | EFO_0000212 | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Polyomavirus infections | D027601 | EFO_0007451 | — | — | — | — | — | 1 | 1 |
Secondary hyperparathyroidism | D006962 | EFO_1001173 | — | — | — | — | — | 1 | 1 |
Cytomegalovirus infections | D003586 | EFO_0001062 | B25 | — | — | — | — | 1 | 1 |
Thrombasthenia | D013915 | — | D69.1 | — | — | — | — | 1 | 1 |
Hematopoietic stem cell transplantation | D018380 | — | — | — | — | — | — | 1 | 1 |
Hemoglobin sc disease | D006450 | EFO_1001797 | D57.2 | — | — | — | — | 1 | 1 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | — | — | — | — | 1 | 1 |
B-cell lymphoma | D016393 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Alemtuzumab |
INN | alemtuzumab |
Description | Immunoglobulin G 1 (human-rat monodonal CAMPATH-1H 71-chain anti-human antigen CD52), disulfide with human-rat monoclonal CAMPATH-1H light chain, dimer |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | >1CE1:H|PROTEIN (CAMPATH-1H:HEAVY CHAIN)
QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLEWIGFIRDKAKGYTTEYNPSVKGRVTMLVDTSKNQ
FSLRLSSVTAADTAVYYCAREGHTAAPFDYWGQGSLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTV
SWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVE
>1CE1:L|PROTEIN (CAMPATH-1H:LIGHT CHAIN)
DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKLLIYNTNNLQTGVPSRFSGSGSGTDFTFTISSLQP
EDIATYYCLQHISRPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQ
ESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR |
PDB | 1BEY, 1BFO, 1CE1, 6OBD |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201587 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB00087 |
UNII ID | 3A189DH42V (ChemIDplus, GSRS) |